Category Specific RSS

colorectal cancer

Top of the class: Rhythm’s latest study results outperform the standard

Colorectal cancer is the third most commonly occurring cancer in men, and the second in women. Yet every year 130…

4 years ago

Rhythm Biosciences appoint mass manufacturer for bowel cancer test kits

Aussie medtech company Rhythm Biosciences (ASX: RHY) is set to improve the screening process of colorectal cancer with manufacturing of…

5 years ago